Maureen Miller, PhD, is an infectious disease epidemiologist with training in medical anthropology. Her career straddles both the academic and public spheres. Dr. Miller has been involved in applied infectious disease prevention research, programming and policy since the 1990s, has published a number of theoretical and research articles in peer reviewed scientific journals, and has a proven track record in attracting funding for the conduct of innovative research in resource poor settings. While a full-time professor at Columbia, she established Bed Stuy West Community Studies, a successful community-academic health research partnership in the largest Black community in North America. In addition to conducting research, Dr. Miller consults regularly with governments and non-governmental organizations around the world. Her completed projects range from the evaluation of an urban syringe exchange program that resulted in national program expansion, to the development of an analytic framework to evaluate international health programs in terms of health equity and human rights, to the creation of a strategic five year HIV prevention plan for a major U.S. city. Dr. Miller's current interests focus on understanding how complex social problems impact population health, as well as on possible solutions. She is particularly interested in applying collaborative change through collective impact. Collective impact occurs when organizations from different sectors agree to solve a specific social problem using a common agenda, aligning their efforts, and using common measures of success.
Areas of Expertise
Research Design and Methods, Disparities / Inequalities in Health, Social Epidemiology, Women's Health, Human Rights, HIV/AIDS, Sexually Transmitted Infections, Infectious Disease, Sex Education and Safe Sex, Infectious Disease and Drug Use
Miller M, Hagan E. Integrated biological behavioral surveillance in pandemic threat warning systems. Bulletin of the World Health Organization. 2017; 95:62-68. doi.org/10.2471/BLT.16.175984.
Miller M, Korves CT, Fernandez T. The social epidemiology of HIV transmission among African American women who use drugs and their social network members. AIDS Care. 2007;19(7):858-65.
Miller M, Liao Y, Manchikanti-Gomez A, Gaydos CA, DMellow D. Prevalence and incidence rates of Trichomonas vaginalis among African American women who use drugs in New York City: Associations and co-infections. Journal of Infectious Disease. 2008;197:503-9.
Miller M, Liao Y, Wagner M, Corves K. HIV, the clustering of sexually transmitted infections (STIs) and sex risk among African American women who use drugs. Sexually Transmitted Diseases. 2008; 35(7):696-702.
Miller M, Neaigus A. An economy of risk: resource acquisition strategies of inner city women who use drugs. International Journal of Drug Policy 2002; 13(5):399-408.
Gwizdala RA, Miller M, Bhat M, Vavagiakis P, Henry C, Neaigus A, Shi Q and Lowy FD. Staphylococcus aureus Among Drug Users: Identification of Hidden Networks. American Journal of Public Health. 2011;101:1268-76.
Lowy FD, Miller M. Staphylococcus aureus disease among drug users: understanding transmission dynamics and pathogenesis. Lancet Infectious Diseases 2002;2 :605-612.
Miller M, Neaigus A. Networks, resources and risk among women who use drugs. Social Science & Medicine 2001;52(6):967-978.
Miller M, Eskild A, Mella I, Moi H, Magnus P. Gender differences in syringe exchange program use patterns in Oslo, Norway. Addiction 2001; 96(11):1639-51.
Miller M, Meyer L, Boufassa F, Persoz A, Sarr A, Robain M, Spira A and the SEROCO Study Group. Sexual behavior changes and protease inhibitor therapy. AIDS 2000;14 (4):F33-F39.